Literature DB >> 28592145

High expression of COX5B is associated with poor prognosis in breast cancer.

Shui-Ping Gao1,2, He-Fen Sun1,2, Wen-Yan Fu1,2, Liang-Dong Li1,2, Yang Zhao1,2, Meng-Ting Chen1,2, Wei Jin1,2.   

Abstract

BACKGROUND: Cytochrome c oxidase subunit VB (COX5B), a subunit of mammalian COX, takes roles in COX assembling and functions. Online database predicts high COX5B transcription may be associated with worse disease-free survival (DFS). However, the clinical implications of COX5B in breast cancer remain unclear.
METHODS: We carried out immunohistochemistry on tissue microarrays of 244 patients with invasive ductal breast carcinoma to detected COX5B expression.
RESULTS: Our results suggest that COX5B protein level might be associated with tumor size. COX5B overexpression indicated a worse DFS (p < 0.05) in breast cancer. Furthermore, high COX5B expression may act as an independent factor for worse DFS in breast cancer.
CONCLUSIONS: Cumulatively, our findings suggest that COX5B might serve as an important prognostic factor for breast cancer.

Entities:  

Keywords:  COX5B; IHC; breast cancer; disease-free survival; mitochondria

Mesh:

Substances:

Year:  2017        PMID: 28592145     DOI: 10.2217/fon-2017-0058

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  3 in total

Review 1.  Multiple Mechanisms Regulate Eukaryotic Cytochrome C Oxidase.

Authors:  Rabia Ramzan; Bernhard Kadenbach; Sebastian Vogt
Journal:  Cells       Date:  2021-02-28       Impact factor: 6.600

Review 2.  Role of cytochrome c oxidase nuclear-encoded subunits in health and disease.

Authors:  K Čunátová; D P Reguera; J Houštěk; T Mráček; P Pecina
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

3.  COX5B-Mediated Bioenergetic Alterations Modulate Cell Growth and Anticancer Drug Susceptibility by Orchestrating Claudin-2 Expression in Colorectal Cancers.

Authors:  Yu-De Chu; Siew-Na Lim; Chau-Ting Yeh; Wey-Ran Lin
Journal:  Biomedicines       Date:  2021-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.